Pancreatic cancer-associated stroma production.
暂无分享,去创建一个
[1] H. Friess,et al. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. , 1998, The Journal of clinical investigation.
[2] H. Friess,et al. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells , 2002, Molecular carcinogenesis.
[3] M. Kornmann,et al. Chemosensitivity testing and test-directed chemotherapy in human pancreatic cancer. , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[4] E. Furth,et al. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. , 2006, Cancer research.
[5] M. Goggins,et al. Gene Expression Profiling of Tumor–Stromal Interactions between Pancreatic Cancer Cells and Stromal Fibroblasts , 2004, Cancer Research.
[6] R. Hruban,et al. Genetic progression in the pancreatic ducts. , 2000, The American journal of pathology.
[7] M. Korc,et al. Vascular Endothelial Growth Factor-Trap Suppresses Tumorigenicity of Multiple Pancreatic Cancer Cell Lines , 2004, Clinical Cancer Research.
[8] Birgir Gudjonsson,et al. Cancer of the pancreas: 50 years of surgery , 1987, Cancer.
[9] R. Hruban,et al. Molecular pathogenesis of pancreatic cancer. , 2006, Best practice & research. Clinical gastroenterology.
[10] M. Korc,et al. Connective tissue growth factor–specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer , 2006, Molecular Cancer Therapeutics.
[11] R. Hruban,et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.
[12] M. Korc,et al. Growth factor–induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells , 2005, The Journal of cell biology.
[13] P. Chiao,et al. Identification of an Autoregulatory Feedback Pathway Involving Interleukin-1α in Induction of Constitutive NF-κB Activation in Pancreatic Cancer Cells* , 2004, Journal of Biological Chemistry.
[14] T. Greten,et al. Stat3 and NF-κB activation prevents apoptosis in pancreatic carcinogenesis ☆ ☆☆ , 2002 .
[15] R. DePinho,et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. , 2003, Genes & development.
[16] M. Miyazaki,et al. Effect of differences in cancer cells and tumor growth sites on recruiting bone marrow‐derived endothelial cells and myofibroblasts in cancer‐induced stroma , 2005, International journal of cancer.
[17] P. Guillou,et al. Biology of pancreatic cancer. , 1991, Gut.
[18] R. Kuick,et al. The Molecular Basis of Pancreatic Fibrosis: Common Stromal Gene Expression in Chronic Pancreatitis and Pancreatic Adenocarcinoma , 2004, Pancreas.
[19] M. Korc,et al. Soluble type II transforming growth factor-beta receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis. , 2002, Molecular cancer therapeutics.
[20] M. Korc,et al. Soluble Type II Transforming Growth Factor-β (TGF-β) Receptor Inhibits TGF-β Signaling in COLO-357 Pancreatic Cancer Cells in Vitro and Attenuates Tumor Formation , 2001 .
[21] H. Hameister,et al. Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells , 1999, Oncogene.
[22] A. Buck,et al. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. , 2005, Gastroenterology.
[23] J. Trevino,et al. c-Src Regulates Constitutive and EGF-mediated VEGF Expression in Pancreatic Tumor Cells Through Activation of Phosphatidyl Inositol-3 Kinase and p38 MAPK , 2005, Pancreas.
[24] D. Winchester,et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. , 1999, Journal of the American College of Surgeons.
[25] M. Korc,et al. Aberrant Expression of Neuropilin-1 and -2 in Human Pancreatic Cancer Cells , 2004, Clinical Cancer Research.
[26] W. Nealon,et al. Inflammatory Mechanisms Contributing to Pancreatic Cancer Development , 2004, Annals of surgery.
[27] H. Friess,et al. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival , 1993 .
[28] M. Tempero,et al. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. , 1999, Gastroenterology.
[29] G. Adler,et al. Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells. , 2006, Cancer research.
[30] H. Friess,et al. Desmoplastic Reaction Influences Pancreatic Cancer Growth Behavior , 2004, World Journal of Surgery.
[31] H. Friess,et al. Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.